Facebook Pixel BiomatiQ Inaugurates State-of-the-Art, Fully Automated Production Line for Ready-to-Use Culture Media | Bio Spectrum - business - Lee esta historia en Magzter.com
Vuélvete ilimitado con Magzter GOLD

Vuélvete ilimitado con Magzter GOLD

Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo

$149.99
 
$74.99/Año

Intentar ORO - Gratis

BiomatiQ Inaugurates State-of-the-Art, Fully Automated Production Line for Ready-to-Use Culture Media

Bio Spectrum

|

BioSpectrum India May 2025

Hyderabad, India - BiomatiQ, a leading life science products distribution company, has marked a significant milestone with the inauguration of its state-of-the-art, fully automated production line for ready-to-use culture media.

BiomatiQ Inaugurates State-of-the-Art, Fully Automated Production Line for Ready-to-Use Culture Media

Founded in 2017, BiomatiQ has established a strong presence in the industry with a team spread across India. This latest advancement marks a pivotal transition into manufacturing, underscoring the company's commitment to delivering high-quality products and services.

A Grand Inauguration Ceremony

The grand ceremony featured a ribbon-cutting by Sri K.V.G.K. Raju, an esteemed figure, known for his immense contributions to the scientific and industrial domains. The momentous ribbon-cutting was followed by the ceremonial lighting of the inauguration diya, signifying a bright and prosperous beginning for this new phase in BiomatiQ's journey. The diya was lit by Sri K.V.G.K. Raju, along with Sri Pavan Kumar, Sri Natarajan, Sri Jean-Francois Jochim from Biokar Diagnostics, Sri Rakesh Aggarwal and Sri Omkaranath, symbolizing unity, collaboration, and enlightenment.

The presence of respected dignitaries and industry leaders added gravitas to the event, highlighting the importance of this new facility not only for BiomatiQ but for the life sciences eco-system.

A Facility Built on Quality and Compliance

BiomatiQ's new greenfield facility has been meticulously designed with a strong foundation in Quality by Design (QbD) principles. The infrastructure supports unidirectional men and material flow, ensuring minimal risk of cross-contamination. At the heart of the facility lies a Grade A/B cleanroom, dedicated to the aseptic filling of RTU media. Every component and layout decision has been made to comply with cGMP and WHO standards.

The seamless integration of design, compliance, and technology ensures not just regulatory adherence, but also operational excellence. BiomatiQ’s investment in this facility reflects its commitment to raising the bar for quality in the Indian manufacturing landscape.

Automated Processes for Enhanced Quality

MÁS HISTORIAS DE Bio Spectrum

Bio Spectrum

Bio Spectrum

MAHE teams up with OpenAI to integrate AI to enhance outcomes

Manipal Academy of Higher Education (MAHE), an Institution of Eminence Deemed to be University in Karnataka, has partnered with OpenAI to integrate advanced artificial intelligence (AI) tools across teaching, research, and academic administration.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Jubilant Bhartia Foundation & McGill University to launch CoE in AI education

The Jubilant Bhartia Foundation in collaboration with McGill University (Canada), has signed a Memorandum of Understanding (MoU) to create the Centre of Excellence (CoE) in artificial intelligence (AI) Education and Research.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Heeding Auditory Warning Signs

By 2050, nearly 2.5 billion people are projected to have some degree of hearing loss, and more than 700 million might require hearing rehabilitation. That's according to the World Health Organization (WHO).

time to read

2 mins

April 2026

Bio Spectrum

Bio Spectrum

Botanic Healthcare on-boards Narahari Naidu as Group Chief Financial Officer

Secundarabad-based Botanic Healthcare, a globally leading nutraceutical company, has announced the appointment of Narahari Naidu as its Group Chief Financial Officer (CFO).

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Paras Health ropes in Balkishan Sharma as Group CHRO and Business Transformation Officer

Paras Health has announced the appointment of Balkishan Sharma as Group Chief Human Resources Officer (Group CHRO) and Business Transformation Officer.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Parse Biosciences unveils Evercode Whole Transcriptome V4 with shorter workflow

Parse Biosciences, a Qiagen company, has announced the launch of the new Evercode Whole Transcriptome v4 product line, delivering expanded scalability, higher sensitivity and a simplified workflow for single-cell RNA sequencing. Evercode v4 supports extraordinary scalability of up to five million cells and 384 samples in a single run, enabling researchers

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

UK deploys new bone scanners to help prevent fractures

Tens of thousands of patients at risk of osteoporosis and other bone conditions will get faster access to vital bone scans, as 20 new scanners are rolled out across England.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Cytiva expands Fast Trak process development and validation services facility in India

Cytiva, a Danaher company and a leader in the life sciences industry, has inaugurated an expanded facility for Fast Trak process development (PD) and validation services in Bengaluru.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

ΑΙ TAKES INDIAN PHARMA REINS

The Indian pharmaceutical sector, one of the largest in the world, is undergoing a strategic transformation in the way it operates. As artificial intelligence (AI) gains prominence across the industry, companies are actively adopting Al-driven solutions to enhance efficiency across the entire pharmaceutical ecosystem. Organisations are investing in AI training programmes to keep their workforce future-ready, foster innovation, strengthen supply chains, and transition away from manual record-keeping. In this industry analysis, experts share their perspectives on how AI is shaping the future of the pharma sector.

time to read

10 mins

April 2026

Bio Spectrum

NIH halts arm of clinical trial evaluating potential stroke treatment

The National Institutes of Health (NIH) in the US has stopped an investigational treatment arm of the Comparison of Anti-coagulation and Anti-platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA) study, following a regular review by the Data Safety and Monitoring Board (DSMB).

time to read

1 min

April 2026

Listen

Translate

Share

-
+

Change font size